Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (351)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
16
2024
215
6.110
 Why?
Breast Neoplasms
27
2026
2447
4.250
 Why?
Antineoplastic Agents
23
2023
2192
2.380
 Why?
Immunoconjugates
7
2023
132
2.370
 Why?
Antineoplastic Combined Chemotherapy Protocols
20
2025
1953
2.230
 Why?
Pyrimidines
9
2021
532
2.180
 Why?
Protein Kinase Inhibitors
11
2025
968
1.710
 Why?
Piperazines
5
2023
380
1.590
 Why?
Paclitaxel
6
2022
255
1.490
 Why?
Camptothecin
9
2023
140
1.470
 Why?
Neoplasms
15
2026
2870
1.470
 Why?
Pyrazoles
6
2021
509
1.250
 Why?
Ovarian Neoplasms
5
2025
586
1.230
 Why?
Quinoxalines
2
2020
65
1.220
 Why?
Azepines
3
2020
107
1.150
 Why?
Antibodies, Monoclonal, Humanized
10
2024
985
1.120
 Why?
Histone Deacetylase Inhibitors
4
2024
220
1.120
 Why?
Cyclin-Dependent Kinase 4
2
2018
53
1.010
 Why?
Cyclin-Dependent Kinase 6
2
2018
49
1.010
 Why?
Carcinoma, Lobular
3
2026
56
0.850
 Why?
Neutropenia
4
2022
155
0.820
 Why?
Benzoxazoles
2
2021
20
0.810
 Why?
Xenograft Model Antitumor Assays
12
2026
928
0.730
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1455
0.720
 Why?
Maximum Tolerated Dose
10
2026
212
0.700
 Why?
Breast Neoplasms, Male
2
2018
29
0.690
 Why?
beta Catenin
2
2020
252
0.690
 Why?
Female
59
2026
77976
0.670
 Why?
Chemotherapy, Adjuvant
4
2023
419
0.640
 Why?
Cancer Care Facilities
1
2020
48
0.630
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
154
0.630
 Why?
Receptors, Estrogen
3
2021
457
0.630
 Why?
Tumor Microenvironment
5
2026
732
0.610
 Why?
Nuclear Proteins
3
2026
748
0.610
 Why?
eIF-2 Kinase
1
2019
29
0.610
 Why?
Humans
70
2026
144261
0.580
 Why?
Anthracyclines
3
2023
47
0.570
 Why?
Pyridines
5
2025
605
0.560
 Why?
Taxoids
3
2023
116
0.560
 Why?
Aged
27
2026
25850
0.540
 Why?
Carcinoma, Ductal, Breast
1
2018
88
0.530
 Why?
Aurora Kinase A
4
2020
62
0.530
 Why?
Wnt Signaling Pathway
1
2019
210
0.520
 Why?
Drug Resistance, Neoplasm
4
2020
881
0.510
 Why?
Trastuzumab
4
2023
118
0.510
 Why?
Pyrazines
2
2018
92
0.500
 Why?
Aromatase Inhibitors
3
2025
75
0.490
 Why?
Colonic Neoplasms
1
2018
259
0.480
 Why?
Myocardial Infarction
1
2023
1208
0.470
 Why?
Tumor Suppressor Protein p53
4
2024
529
0.460
 Why?
Cell Line, Tumor
11
2026
3539
0.460
 Why?
Angiopoietin-1
1
2015
12
0.450
 Why?
Angiopoietin-2
1
2015
15
0.450
 Why?
Neoplasm Recurrence, Local
5
2025
1137
0.440
 Why?
Neoadjuvant Therapy
1
2018
462
0.440
 Why?
Middle Aged
28
2026
35762
0.410
 Why?
Medicare
4
2023
881
0.400
 Why?
Uterine Cervical Neoplasms
1
2017
267
0.400
 Why?
Bridged-Ring Compounds
2
2023
31
0.400
 Why?
Adult
29
2026
40262
0.390
 Why?
Colorectal Neoplasms
5
2022
844
0.380
 Why?
Dose-Response Relationship, Drug
6
2022
2026
0.380
 Why?
Tumor Suppressor Proteins
1
2015
321
0.370
 Why?
Proto-Oncogene Proteins c-met
1
2013
75
0.370
 Why?
Cell Proliferation
8
2020
2494
0.370
 Why?
Lung Neoplasms
3
2026
2637
0.370
 Why?
Quinolines
4
2025
190
0.370
 Why?
Antibodies, Monoclonal
4
2024
1519
0.370
 Why?
Recombinant Fusion Proteins
1
2015
674
0.360
 Why?
Treatment Outcome
13
2025
11643
0.360
 Why?
Radiosurgery
3
2025
400
0.360
 Why?
Antineoplastic Agents, Immunological
3
2019
199
0.360
 Why?
Point Mutation
1
2013
243
0.360
 Why?
Neoplasm Metastasis
5
2026
688
0.360
 Why?
Triazoles
1
2013
184
0.350
 Why?
Angiogenesis Inhibitors
3
2018
236
0.340
 Why?
Mice, Nude
6
2020
682
0.330
 Why?
Aged, 80 and over
10
2025
8243
0.320
 Why?
Clinical Trials, Phase I as Topic
2
2020
52
0.320
 Why?
Carcinoma, Renal Cell
1
2013
234
0.320
 Why?
Mitochondria
1
2017
983
0.320
 Why?
Heart Failure
1
2023
2314
0.310
 Why?
Histones
3
2023
668
0.310
 Why?
Genes, BRCA2
1
2009
33
0.310
 Why?
Adaptor Proteins, Signal Transducing
2
2026
427
0.310
 Why?
Genes, BRCA1
1
2009
45
0.310
 Why?
Molecular Targeted Therapy
3
2019
431
0.300
 Why?
Biomarkers, Tumor
2
2014
1313
0.290
 Why?
BRCA2 Protein
1
2009
67
0.290
 Why?
Apoptosis
7
2024
2430
0.290
 Why?
Pregnancy Complications, Neoplastic
1
2009
63
0.290
 Why?
Thrombophilia
1
2009
88
0.290
 Why?
Neoplasm Staging
5
2021
1461
0.280
 Why?
Kidney Neoplasms
1
2013
412
0.280
 Why?
Mice
12
2026
18329
0.280
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
132
0.280
 Why?
Adenine
2
2021
339
0.270
 Why?
Receptors, Progesterone
2
2021
356
0.270
 Why?
DNA-Binding Proteins
1
2015
1497
0.260
 Why?
Aminopyridines
3
2026
127
0.250
 Why?
Nicotinamide Phosphoribosyltransferase
1
2026
8
0.240
 Why?
Models, Biological
1
2014
1820
0.240
 Why?
Cell Cycle Proteins
3
2026
628
0.230
 Why?
Selective Estrogen Receptor Modulators
1
2025
36
0.230
 Why?
Doxorubicin
3
2024
397
0.220
 Why?
Cardiorespiratory Fitness
1
2025
72
0.220
 Why?
Animals
15
2026
38030
0.220
 Why?
Biopsy
3
2018
1075
0.210
 Why?
Cyclophosphamide
2
2018
266
0.200
 Why?
DNA Repair
1
2026
255
0.200
 Why?
Trans-Activators
1
2026
405
0.200
 Why?
Wound Healing
1
2026
351
0.190
 Why?
Disease Models, Animal
3
2021
4556
0.190
 Why?
Brain Neoplasms
3
2025
1318
0.190
 Why?
United States
5
2023
15876
0.190
 Why?
Liver Neoplasms
1
2009
780
0.190
 Why?
Cyclin-Dependent Kinase 9
1
2022
18
0.180
 Why?
Histone Deacetylase 1
1
2022
23
0.180
 Why?
Aurora Kinases
2
2012
28
0.180
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
44
0.180
 Why?
Topoisomerase I Inhibitors
2
2022
19
0.180
 Why?
Administration, Oral
3
2022
847
0.180
 Why?
Disease Progression
4
2019
2840
0.170
 Why?
Fluorouracil
1
2022
235
0.170
 Why?
Acetylation
1
2022
252
0.170
 Why?
Androstadienes
1
2021
76
0.170
 Why?
Biliary Tract Neoplasms
1
2021
30
0.170
 Why?
Arrhythmias, Cardiac
1
2023
360
0.160
 Why?
Drug Administration Schedule
3
2017
778
0.160
 Why?
Heterografts
1
2021
143
0.160
 Why?
Carboplatin
1
2021
160
0.160
 Why?
Diarrhea
2
2019
192
0.160
 Why?
Hospitals, University
1
2021
176
0.160
 Why?
Male
16
2026
72035
0.160
 Why?
Necrosis
2
2019
244
0.160
 Why?
Histone Deacetylases
1
2022
210
0.160
 Why?
Cancer Survivors
1
2025
326
0.160
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
63
0.160
 Why?
Fatigue
2
2022
361
0.160
 Why?
Immunotherapy
2
2023
652
0.150
 Why?
Immune System
1
2021
179
0.150
 Why?
Clinical Trials as Topic
3
2016
1050
0.150
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
39
0.150
 Why?
Benzodiazepines
1
2021
165
0.150
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
139
0.150
 Why?
Corneal Ulcer
1
1999
20
0.150
 Why?
Kaplan-Meier Estimate
1
2021
964
0.150
 Why?
Tumor Cells, Cultured
1
2020
919
0.140
 Why?
Albumins
1
2019
118
0.140
 Why?
Aquaporin 4
1
2019
98
0.140
 Why?
Sucrase
1
1998
1
0.140
 Why?
Maintenance Chemotherapy
1
2018
42
0.140
 Why?
Vascular Endothelial Growth Factor A
2
2018
557
0.140
 Why?
Microvilli
1
1998
75
0.140
 Why?
Cornea
1
1999
155
0.140
 Why?
Cytokines
1
2026
2061
0.140
 Why?
Nausea
1
2018
111
0.140
 Why?
Mice, Inbred BALB C
1
2020
1253
0.130
 Why?
Drug Therapy, Combination
1
2020
1044
0.130
 Why?
Breast
1
2018
157
0.130
 Why?
Antibodies, Bispecific
1
2018
64
0.130
 Why?
Radiotherapy, Adjuvant
1
2018
222
0.130
 Why?
Purines
1
2018
187
0.130
 Why?
Topotecan
1
2017
17
0.130
 Why?
Benzimidazoles
1
2018
190
0.130
 Why?
Isoflavones
1
2017
26
0.130
 Why?
Bacterial Infections
1
1999
246
0.130
 Why?
Calcium-Binding Proteins
1
2018
219
0.130
 Why?
Mastectomy
1
2018
162
0.130
 Why?
Imidazoles
1
2018
254
0.130
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
23
0.130
 Why?
Carbolines
1
2017
35
0.130
 Why?
Survival Analysis
1
2020
1382
0.130
 Why?
Inhibitory Concentration 50
2
2016
91
0.120
 Why?
Programmed Cell Death 1 Receptor
1
2019
264
0.120
 Why?
Hypertension
2
2018
1254
0.120
 Why?
Cell Survival
1
2019
1098
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
99
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
319
0.120
 Why?
Retrospective Studies
4
2025
17009
0.120
 Why?
GPI-Linked Proteins
1
2016
80
0.120
 Why?
Neoplasms, Second Primary
1
2016
100
0.120
 Why?
Antibodies, Neoplasm
1
2015
34
0.110
 Why?
Tumor Protein p73
1
2015
18
0.110
 Why?
Phosphorylation
1
2019
1732
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2024
1180
0.110
 Why?
Risk Reduction Behavior
1
2016
225
0.110
 Why?
Hodgkin Disease
1
2016
171
0.110
 Why?
Nanoparticles
1
2021
519
0.110
 Why?
Oxazoles
2
2025
48
0.110
 Why?
Maytansine
1
2014
18
0.110
 Why?
Demography
1
2015
284
0.100
 Why?
Brain Edema
1
2014
62
0.100
 Why?
Drug Interactions
1
2015
397
0.100
 Why?
Protein Kinases
1
2015
315
0.100
 Why?
Survival Rate
2
2019
2088
0.100
 Why?
Exercise
1
2025
2193
0.100
 Why?
Threonine
1
2013
46
0.100
 Why?
Sulfones
1
2014
127
0.100
 Why?
Tumor Stem Cell Assay
1
2012
34
0.100
 Why?
Quinazolines
2
2025
266
0.100
 Why?
Drug Evaluation, Preclinical
1
2013
194
0.090
 Why?
Randomized Controlled Trials as Topic
1
2019
1705
0.090
 Why?
Diabetes Mellitus, Type 2
2
2025
2516
0.090
 Why?
Glycine
1
2014
187
0.090
 Why?
Bacteria
1
1999
889
0.090
 Why?
Drug Design
1
2013
173
0.090
 Why?
Methionine
1
2013
162
0.090
 Why?
Time Factors
2
2020
7155
0.090
 Why?
Heterozygote
1
2013
315
0.090
 Why?
In Situ Hybridization, Fluorescence
1
2013
322
0.090
 Why?
Intestinal Mucosa
1
1998
676
0.090
 Why?
Treatment Failure
1
2013
363
0.090
 Why?
Analgesics, Opioid
1
2021
1131
0.090
 Why?
Disease-Free Survival
1
2014
768
0.090
 Why?
Neovascularization, Pathologic
1
2013
286
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
339
0.080
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
230
0.080
 Why?
Cluster Analysis
1
2012
519
0.080
 Why?
Carcinoma in Situ
1
2011
44
0.080
 Why?
Risk Assessment
1
2020
3637
0.080
 Why?
Computational Biology
1
2015
680
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
85
0.080
 Why?
Risk Factors
2
2025
10699
0.080
 Why?
Colorado
1
2020
4562
0.080
 Why?
Cellular Senescence
1
2012
226
0.080
 Why?
Sequence Analysis, DNA
1
2013
824
0.080
 Why?
Mutation
2
2012
4085
0.080
 Why?
Tumor Burden
1
2010
319
0.070
 Why?
Gastric Emptying
1
2009
36
0.070
 Why?
Keratinocytes
1
2010
248
0.070
 Why?
Pregnancy Trimester, Second
1
2009
82
0.070
 Why?
Enteric Nervous System
1
2009
25
0.070
 Why?
Stomach
1
2009
109
0.070
 Why?
Mastectomy, Segmental
1
2009
108
0.070
 Why?
Pregnancy Trimester, First
1
2009
135
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
186
0.070
 Why?
Muscle, Smooth
1
2009
151
0.070
 Why?
Lymph Node Excision
1
2009
173
0.070
 Why?
Diabetes Mellitus, Experimental
1
2009
198
0.070
 Why?
Risk
1
2009
909
0.060
 Why?
Cell Adhesion Molecules
2
2019
177
0.060
 Why?
Infusions, Intravenous
2
2019
423
0.060
 Why?
Pentosyltransferases
1
2026
6
0.060
 Why?
Antigens, Neoplasm
2
2019
271
0.060
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
1
2026
15
0.060
 Why?
Phosphodiesterase 4 Inhibitors
1
2026
12
0.060
 Why?
Prognosis
2
2018
4278
0.060
 Why?
Cyclopropanes
1
2026
83
0.060
 Why?
Acrylamides
1
2026
70
0.060
 Why?
Gene Expression Profiling
1
2012
1782
0.060
 Why?
Phthalazines
1
2026
64
0.060
 Why?
Cyclic AMP Response Element-Binding Protein
1
2026
145
0.060
 Why?
CD8-Positive T-Lymphocytes
2
2023
917
0.060
 Why?
Alveolar Epithelial Cells
1
2026
120
0.060
 Why?
Benzamides
1
2026
224
0.050
 Why?
Accelerometry
1
2025
119
0.050
 Why?
Cell Cycle
2
2018
596
0.050
 Why?
Combined Modality Therapy
2
2019
1264
0.050
 Why?
Mesylates
1
2022
7
0.050
 Why?
Follow-Up Studies
2
2025
5389
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
69
0.050
 Why?
Signal Transduction
2
2014
5221
0.050
 Why?
Oxygen Consumption
1
2025
724
0.050
 Why?
Clinical Protocols
1
2023
282
0.040
 Why?
Ligands
1
2024
673
0.040
 Why?
RNA, Small Interfering
1
2024
634
0.040
 Why?
Chimerism
1
2021
35
0.040
 Why?
Lymphocyte Subsets
1
2021
83
0.040
 Why?
Lymphoid Tissue
1
2021
80
0.040
 Why?
Blood Glucose
3
2025
2312
0.040
 Why?
Liver
1
2009
1884
0.040
 Why?
Mice, SCID
1
2021
369
0.040
 Why?
Hormones
1
2020
134
0.040
 Why?
SEER Program
1
2021
224
0.040
 Why?
Mice, Inbred NOD
1
2021
610
0.040
 Why?
Bacteriological Techniques
1
1999
68
0.040
 Why?
Immunohistochemistry
2
2016
1715
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
Tissue Distribution
1
2018
327
0.030
 Why?
Monosaccharide Transport Proteins
1
1998
56
0.030
 Why?
Infant, Newborn
1
2009
6424
0.030
 Why?
Anemia
1
2019
187
0.030
 Why?
Insulin Resistance
1
2025
1232
0.030
 Why?
Intestine, Small
1
1998
166
0.030
 Why?
Biological Transport
1
1998
412
0.030
 Why?
Pregnancy
1
2009
7180
0.030
 Why?
In Vitro Techniques
1
1998
1047
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
112
0.030
 Why?
Cetuximab
1
2016
111
0.030
 Why?
Retreatment
1
2016
77
0.030
 Why?
Neoplasm Transplantation
1
2016
251
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
191
0.030
 Why?
Carotid Artery Diseases
1
1996
68
0.030
 Why?
Platinum
1
2016
50
0.030
 Why?
Arterial Occlusive Diseases
1
1996
90
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
253
0.030
 Why?
History, Ancient
1
2015
55
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
674
0.030
 Why?
Transcription Factors
1
2023
1739
0.030
 Why?
C-Peptide
1
1996
186
0.030
 Why?
Carotid Arteries
1
1996
199
0.030
 Why?
Femoral Artery
1
1996
189
0.030
 Why?
Databases, Genetic
1
2015
248
0.030
 Why?
Kinetics
1
1998
1627
0.030
 Why?
Diabetic Angiopathies
1
1996
254
0.030
 Why?
Biomarkers
2
2016
4254
0.030
 Why?
DNA Damage
1
2017
428
0.030
 Why?
Mice, Knockout
1
2021
3119
0.030
 Why?
Cross-Sectional Studies
1
2025
5813
0.030
 Why?
Quality of Life
1
2025
3166
0.020
 Why?
Opioid-Related Disorders
1
2021
576
0.020
 Why?
Phenotype
1
2021
3157
0.020
 Why?
Glucose
1
1998
1046
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
257
0.020
 Why?
Tomography, X-Ray Computed
2
2016
2730
0.020
 Why?
Drug Combinations
1
2013
390
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
459
0.020
 Why?
Lipids
1
1996
700
0.020
 Why?
Biopsy, Needle
1
2011
183
0.020
 Why?
Proto-Oncogene Proteins
1
2014
623
0.020
 Why?
HT29 Cells
1
2010
37
0.020
 Why?
Enzyme Inhibitors
1
2014
824
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
433
0.020
 Why?
Cohort Studies
1
2021
5935
0.020
 Why?
Transcription, Genetic
1
2017
1495
0.020
 Why?
ErbB Receptors
1
2013
627
0.020
 Why?
Ki-67 Antigen
1
2010
117
0.020
 Why?
Capillary Permeability
1
2010
134
0.020
 Why?
Gastrointestinal Motility
1
2009
29
0.020
 Why?
Patient Selection
1
2013
719
0.020
 Why?
Biological Clocks
1
2009
48
0.020
 Why?
Patient Satisfaction
1
2013
704
0.020
 Why?
Tomography, Emission-Computed, Single-Photon
1
2009
103
0.020
 Why?
Microscopy, Electron
1
2009
415
0.020
 Why?
Positron-Emission Tomography
1
2010
323
0.020
 Why?
Membrane Proteins
1
2015
1165
0.020
 Why?
Rats, Wistar
1
2009
451
0.020
 Why?
Algorithms
1
2015
1834
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3857
0.020
 Why?
Insulin
1
1996
2501
0.010
 Why?
Adolescent
1
2024
22281
0.010
 Why?
Brain
1
2014
2930
0.010
 Why?
Rats
1
2009
5592
0.010
 Why?
Young Adult
1
2014
13990
0.010
 Why?
Tunica Media
1
1996
36
0.010
 Why?
Cholesterol, HDL
1
1996
194
0.010
 Why?
Fasting
1
1996
276
0.010
 Why?
Cholesterol
1
1996
399
0.010
 Why?
Regression Analysis
1
1996
998
0.010
 Why?
Ultrasonography
1
1996
768
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (351) concept(s)
_
Co-Authors Expand Description
See all (75) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)